Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	587	536	541	584	630	696
Market Cap Growth	-1.52%	-0.95%	-7.35%	-7.29%	-9.50%	-32.33%
Enterprise Value	575	418	455	466	510	337
Last Close Price	5.89	5.34	5.19	5.18	5.30	5.35
PE Ratio	1532.55	123.63	-	-	40.16	16.54
Forward PE	210.36	157.06	79.24	-	82.43	-
PS Ratio	1.53	1.44	1.65	1.99	2.59	3.49
PB Ratio	0.77	0.67	0.72	0.71	0.75	0.79
P/TBV Ratio	2.04	1.26	1.43	1.44	1.51	1.07
P/FCF Ratio	20.57	15.84	15.45	13.86	15.44	-
P/OCF Ratio	19.30	14.76	15.05	12.97	14.11	-
EV/Sales Ratio	1.50	1.13	1.39	1.59	2.10	1.69
EV/EBITDA Ratio	13.97	7.46	8.55	11.38	15.73	113.34
EV/EBIT Ratio	-	56.47	71.47	-	-	-
EV/FCF Ratio	20.16	12.35	13.01	11.07	12.52	-
Debt / Equity Ratio	0.14	0.06	0.09	0.09	0.05	0.06
Debt / EBITDA Ratio	2.54	0.83	1.24	1.73	1.18	9.99
Debt / FCF Ratio	3.67	1.46	1.98	1.85	1.00	-
Asset Turnover	0.39	0.39	0.33	0.29	0.24	0.17
Inventory Turnover	1.74	2.02	1.91	1.89	1.99	1.85
Quick Ratio	1.46	2.57	2.35	2.08	2.16	4.28
Current Ratio	2.47	3.57	3.20	2.80	2.90	4.84
Return on Equity (ROE)	0.05%	0.56%	-2.14%	-3.58%	1.81%	3.53%
Return on Assets (ROA)	-0.56%	0.48%	0.40%	-1.04%	-0.79%	-1.40%
Return on Capital (ROIC)	-0.66%	0.56%	0.46%	-1.19%	-0.88%	-1.71%
Return on Capital Employed (ROCE)	-	0.90%	0.80%	-	-	-
Earnings Yield	0.07%	0.81%	-3.11%	-5.12%	2.49%	6.05%
FCF Yield	4.86%	6.31%	6.47%	7.22%	6.48%	-2.53%
Buyback Yield / Dilution	2.39%	5.61%	6.46%	7.74%	5.66%	5.82%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.